Cell Biotech Co. Ltd. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
7,800
10,403
17,505
18,499
18,198
Depreciation, Depletion & Amortization
813
1,107
1,247
1,414
1,647
Other Funds
1,006
551
1,333
1,496
966
Funds from Operations
9,619
12,060
20,084
18,417
20,811
Changes in Working Capital
631
2,152
1,849
426
1,717
Net Operating Cash Flow
8,988
9,907
18,236
17,991
22,528
Capital Expenditures
6,481
1,555
3,384
2,157
5,581
Sale of Fixed Assets & Businesses
2
1
22
-
11
Purchase/Sale of Investments
474
6,785
11,816
9,502
1,462
Net Investing Cash Flow
7,647
8,073
14,967
11,537
7,414
Cash Dividends Paid - Total
1,158
1,158
1,158
3,088
4,246
Issuance/Reduction of Debt, Net
800
-
-
-
-
Net Financing Cash Flow
1,958
1,158
1,158
3,088
11,907
Net Change in Cash
578
626
1,887
3,322
3,022
Free Cash Flow
2,673
8,523
15,104
15,944
17,172
Other Sources
39,171
347
321
301
449
Change in Capital Stock
-
-
-
-
7,661
Exchange Rate Effect
39
50
224
45
186
Other Uses
40,813
81
110
180
831
About Cell Biotech Co.
View Profile
